UBC offers annual awards from the Killam Endowment Fund to Faculty and Teaching Assistants who demonstrate exemplary teaching skills and abilities, with the purpose of recognizing teaching excellence. We are happy to congratulate Dave Ng, Director of the Advanced Molecular Biology Laboratory (AMBL), for winning the Killam Teaching Prize, and Linda Horianopoulos, Graduate Student from the Kronstad Lab, for winning the Killam Graduate…
Read More

Navigating the Regulatory Complexity of Regenerative Medicine in Canada

Regenerative medicine and the advanced therapies being developed by this field have the potential to bring about an entirely novel therapeutic approach to the treatment of human disease. A small number of products have already been approved by regulators around the world, and many more are in development to treat a variety of diseases. This includes many that have not been…
Read More
Field trials on a “consortium” of bacteria that thrive on naphthenic acids are set to begin this summer in northeastern Alberta with a major oilsands bitumen producer. UBC engineers are using directed evolution and genomic tools to encourage naturally occurring bacteria to eat the toxins in oilsands tailings ponds. Field trials on a “consortium” of bacteria that thrive on naphthenic…
Read More

KPU Study Receives Funding to Unlock the Power of Fungi

Tucked away in a lab at Kwantlen Polytechnic University’s Langley campus is a dark room with fungi. To someone without expertise or experience in the field, it looks like a shelf of mold in glass jars. But to the researchers working at the Institute for Sustainable Horticulture (ISH), this fungi may open the door to a number of horticultural innovations,…
Read More
The BC Tech Association (BC Tech) is proud to announce the finalists for the 2019 Technology Impact Awards (TIAs). “The TIA finalists are each excellent examples of companies, organizations and individuals who are fuelling new levels of growth and global competitiveness across British Columbia,” said Jill Tipping, BC Tech President and CEO. “Recognizing and celebrating these innovators is part of…
Read More
Previous work from this group has suggested that the structure of lipid nanoparticles (LNPs) contained inverted micelles that protect the siRNA More recent data suggested this is not the case. This publication provides further evidence to overturn the existing paradigm of LNP formation and provides insight into particle formation through a series of events involving the fusion of precursor particles as a result of neutralising the pH.
Read More
Genome BC is pleased to announce $1 million in funding to LightIntegra Technology (LIT). LIT has developed the first analyzer to provide a routine test for platelet activation status. A Vancouver based medical device company, LIT is focused on reducing the failure to achieve the desired level of blood platelets in a patient following a platelet transfusion (refractoriness) and reducing costs for…
Read More
In the competition to reach commercialization, many of B.C.’s budding biotech companies are running in a tight race. Yet due to the size of the city’s industry, there is still enough room in the province’s biotech ecosystem for each player to be recognized. “I actually think it is an advantage to be in Vancouver as opposed to somewhere like the…
Read More